International Journal of Pancreatology

, Volume 28, Issue 3, pp 215–220 | Cite as

Stimulated gastrointestinal hormone release and gallbladder contraction during continuous jejunal feeding in patients with pancreatic pseudocyst is inhibited by octreotide

  • Tamás Takács
  • Ferenc Hajnal
  • József Németh
  • János Lonovics
  • Ákos Pap


Background. Continuous enteral feeding, the old-new therapeutic modality in the treatment of patients with acute pancreatitis and those with complications is considered to bypass the cephalic, the gastric, and (at least in part) the intestinal phase of pancreatic secretion. The aim of this study was to test the GI hormonal changes and gallbladder motility during CJF in patients with pancreatic pseudocysts following acute pancreatitis, with or without octreotide pretreatment.

Patients and Methods. In 15 patients with pancreatic pseudocysts, an 8-French (8F) nasojejunal catheter was positioned into the jejunum distal to the ligament of Treitz during duodenoscopy. On test d 1, blood samples were taken for CCK, gastrin, insulin-like immunoreactivity (IRI), glucagon, and glucose measurements prior to and at 20, 40, 60, and 120 min following jejunal saline infusion at a rate of 2 mL/min. The gallbladder volumes were determined simultaneously by ultrasonography. On test d 2, CJF (175 kcal/h) was started by the same route and at the same infusion rate. Analogous measurements were performed as indicated above. On test d 3, 100 µg of octreotide was administered subcutaneously and the previous procedure was repeated. The plasma level of CCK and glucagon and the serum levels of IRI and gastrin were determined by bioassay and radioimmunoassay (RIA), respectively.

Results. Significant changes in hormone levels were not observed during jejunal saline perfusion. However, the levels of CCK (5.7±0.9 pmol), gastrin (10.6±1.3 pmol/L), IRI (27.2±5.8 µIU/mL), glucagon (322.8±32.4 pg/mL), and glucose (5.8±1.0 mmol/L) were significantly increased at 20 min during CJF vs the saline controls (2.0±0.3 pmol, 6.8±1.1 pmol/L, 7.8±0.4 µIU/mL, 172.8±33.4 pg/mL, and 4.5±0.5 mmol/L, respectively) and remained elevated at 40, 60, and 120 min. Octreotide pretreatment eliminated the increases in CCK, gastrin, IRI, and glucagon levels observed during CJF alone. The significant decrease in gallbladder volume during CJF was also prevented by octreotide pretreatment.

Conclusion. Continuous jejunal feeding (CJF) elicited significant increases in gastrointestinal (GI) regulatory hormone (cholecystokinin [CCK], gastrin, IRI, and glucagon) levels and evoked a consecutive gallbladder contraction. These biological responses are eliminated by octreotide pretreatment. Further clinical studies are needed to assess the eventual therapeutic effect of octreotide during CJF in patients with pancreatic pseudocyst.

Key Words

Continuous jejunal feeding pancreatic pseudocyst cholecystokinin level changes octreotide 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Havala T, Shronts E, Cerre F. Nutritional support in acute pancreatitis. Gastroenterol Clin North Am 1989; 18: 525–542.PubMedGoogle Scholar
  2. 2.
    Sitzmann JV, Steinborn PA, Zinner MJ, Cameron JL. Total parenteral nutrition and alternate energy substrates in treatment of severe acute pancreatitis. Surg Gynecol Obstet 1989; 168: 311–317.PubMedGoogle Scholar
  3. 3.
    McClave SA, Spain DA, Snider HL. Nutritional management in acute and chronic pancreatitis, Gastroenterol Clin North Am 1998; 27: 421–434.PubMedCrossRefGoogle Scholar
  4. 4.
    Roslyn JJ, King W, Mann LL, et al. Gallbladder disease in patients with on long-term parenteral nutrition. Gastroenterology 1983; 84: 148–154.PubMedGoogle Scholar
  5. 5.
    Bolondo L, Gaiani S, Testa S, et al. Gallbladder sludge formation during prolonged fasting after gastrointestinal tract surgery. Gut 1985; 26: 734–738.CrossRefGoogle Scholar
  6. 6.
    Kalfarentzos F, Kehagias J, Mead N, Kokkinnis K and Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997; 84: 1665–1669.PubMedCrossRefGoogle Scholar
  7. 7.
    Nakad A, Piessevaux H, Marot JC, Hoang P, Guebel A, Van Steenbergen W, Reynaert M. Is early enteral nutrition in acute pancreatitis dangerous? About 20 patients fed by an endoscopically placed nasogastrojejunal tube. Pancreas 1998; 17: 187–193.PubMedCrossRefGoogle Scholar
  8. 8.
    McClave SA, Snider H, Owens N, Sexton LK. Clinical nutrition in pancreatitis. Dig Dis Sci 1997; 42: 2035–2044.PubMedCrossRefGoogle Scholar
  9. 9.
    Pisters PWT, Ranson JHC. Nutritional support for acute pancreatitis. Surg Gynecol Obstet 1992; 175: 275–284.PubMedGoogle Scholar
  10. 10.
    Stolk MFJ, Van Erpecum KJ, Hiemstra G, Jansen JBMJ, Van Berge-Henegouwen GP. Gallbladder motility and cholecystokinin release during long-term enteral nutrition in patients with Crohn’s Disease. Scand J Gastroenterol 1994; 29: 934–939.PubMedCrossRefGoogle Scholar
  11. 11.
    Ledeboer M, Masclee AM, Biemond I, Lamers CBHW. Gallbladder motility and cholecystokinin secretion during continuous enteral nutrition. Am J Gastroenterol 1997; 92: 2274–2279.PubMedGoogle Scholar
  12. 12.
    Vidon N, Chaussade S, Merite F, Huchet B, Franchisseur C, Bernier JJ. Inhibitory effect of high caloric load of carbohydrates or lipids on human pancreatic secretions: a jejunal brake. Am J Clin Nutr 1993; 50: 231–236.Google Scholar
  13. 13.
    Vidon N, Pfeiffer A, Franchisseur C, Bovet M, Rongier M, Bernier JJ. Effect of different caloric loads in human jejunum on meal stimulated and non stimulated biliopancreatic secretion. Am J Clin Nutr 1988; 47: 400–405.PubMedGoogle Scholar
  14. 14.
    Czakó L, Hajnal F, Németh J, Takács T, Lonovics J. Effect of a liquid meal given as a bolus into the jejunum on human pancreatic secretion. Pancreas 1999; 18: 197–202.PubMedCrossRefGoogle Scholar
  15. 15.
    Beechey-Newman N. Controlled trial of high-dose octreotide in treatment of acute pancreatitis. Dig Dis Sci 1993; 38: 644–647.PubMedCrossRefGoogle Scholar
  16. 16.
    McKay CJ, Imrie CW, Baxter JN. Somatostatin and somatostatin analogues—are they indicated in the management of acute pancreatitis? Gut 1993; 34: 1622–1626.PubMedCrossRefGoogle Scholar
  17. 17.
    Grosman I, Simon D. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am J Gastroenterol 1990; 85: 1061–1072.PubMedGoogle Scholar
  18. 18.
    Uhl W, Büchler MW, Malfertheiner P, Beger HG, Adler G, Geaus W, and the German Pancreatitis Study Group. A randomized, double blind, multicentre trial of octreotide in moderate and severe acute pancreatitis. Gut 1999; 45: 97–104.PubMedCrossRefGoogle Scholar
  19. 19.
    Liddle RA, Goldfine ID, Williams JA. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor and alcohol. Gastroenterology 1984; 87: 542–549.PubMedGoogle Scholar
  20. 20.
    Remák G, Penke B, Németh J, Baláspiri L, Varga L. Experiences with the development of the radioimmunoassay of 15-Leu-Gastrin. Izotóptechnika 1980; 23: 266–279.Google Scholar
  21. 21.
    Hyvarinen A, Nikkila EA. Specific determination of blood glucose with o-toluidine. Clin Chim Acta 1962; 7: 140–144.PubMedCrossRefGoogle Scholar
  22. 22.
    Pap Á, Bálint L, Hamvas J, Balgha V, Topa L, Berger Z, Gál I. Jejunal feeding can promote healing of pancreatic pseudocysts. Int J Pancreatol 1992; 12: 94 (A).Google Scholar
  23. 23.
    Pfeiffer A, Vidon N, Fuerle GE, Chayvialle JA, Bernier JJ. Effect of jejunal infusion of different caloric loads on pancreatic enzyme secretion and gastrointestinal hormone response in man. Eur J Clin Invest 1993; 23: 57–62.PubMedCrossRefGoogle Scholar
  24. 24.
    Ledeboer M, Masclee AM, Biemond I, Lamers CBHW. Effect of intragastric or intraduodenal administration of a polymeric diet on gallbladder motility, small-bowel transit time, and hormone release. Am J Gastroenterol 1998; 93: 2089–2096.PubMedCrossRefGoogle Scholar
  25. 25.
    Bodoky G, Harsányi L, Pap Á. Effect of enteral nutrition on exocrine pancreatic function. Am J Surg 1991; 161: 144–148.PubMedCrossRefGoogle Scholar
  26. 26.
    Uhl W, Anghelacopoulos SE, Friess H., Buchler MW. The role of octreotide and somatostatin in acute and chronic pancreatitis. Digestion 1999; 60 (Suppl. 2): 23–30.PubMedCrossRefGoogle Scholar
  27. 27.
    Gullo L, Barbara L. Treatment of pancreatic pseudocysts with octreotide. Lancet 1991; 338: 540–541.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2001

Authors and Affiliations

  • Tamás Takács
    • 2
  • Ferenc Hajnal
    • 1
  • József Németh
    • 1
  • János Lonovics
    • 1
  • Ákos Pap
    • 2
  1. 1.First Department of MedicineUniversity of SzegedHungary
  2. 2.MÁV HospitalBudapestHungary

Personalised recommendations